Immucell Corp.
ICCC
Market Cap$45.64M
Close$
$6.58
29.7% upside
Current Fair Value
29.7% upsideUndervalued by 29.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $45.64 Million |
|---|---|
| Enterprise Value | $45.64 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.26 |
| Beta | 0.24 |
| Outstanding Shares | 8,935,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -21.03 |
|---|---|
| PEG | -0.03 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 2.54 |
| Enterprise Value to Revenue | 0.01 |
| Enterprise Value to EBIT | -0.08 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Immucell Corp.
CEO: Michael Brigham